Epicardial adipose tissue and insulin resistance in patients with coronary artery disease with or without left ventricular dysfunction

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 80, Issue 4, 2013, Pages 170-176

  Baldasseroni, Samuele ^a   Pratesi, Alessandra ^a   Orso, Francesco ^a   Di Serio, Claudia ^a   Foschini, Alice ^a   Marella, Andrea Giosafat ^a   Bartoli, Nadia ^a   Di Bari, Mauro ^a   Fumagalli, Stefano ^a   Marchionni, Niccolò ^a   Tarantini, Francesca ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Adipokine; Coronary artery disease; Epicardial fat; Insulin resistance; Left ventricular dysfunction

Indexed keywords

ADIPONECTIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; POTASSIUM; RESISTIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EPICARDIUM; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ECHOCARDIOGRAPH; HEART MUSCLE REVASCULARIZATION; POTASSIUM BLOOD LEVEL; CASE CONTROL STUDY; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MIDDLE AGED; PATHOLOGY; PERICARDIUM; PREDICTIVE VALUE;

ADIPOSE TISSUE; AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PERICARDIUM; PREDICTIVE VALUE OF TESTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84937888554     PISSN: None     EISSN: 24651028     Source Type: Journal    
DOI: 10.4081/monaldi.2013.5233     Document Type: Article

References (42)

1. Iozzo P. Myocardial perivascular and epicardial fat. Diabetes Care 2011; 34: 371-379.
2. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-6.
3. Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1.
4. Iacobellis G, Pistilli D, Gucciardo M, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29: 251-5.
5. Iacobellis G, Gioia CR, Di Vito M, et al. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res 2009; 41: 855-60.
6. Mahabadi AA, Massaro JM, Rosito GA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: The Framingham Heart Study. Eur Heart J 2009; 30: 850-6.
7. Iacobellis G, Willens HJ. Echocardiographic Epicardial Fat: A Review of Research and Clinical Applications. J Am Soc Echocardiogr 2009; 22: 1311-9.
8. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304-10.
9. Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high risk echocardiographic epicardial fat thickness. Obesity 2008; 16: 887-92.
10. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005; 90: 6300-2.
11. Park JS, Choi SY, Zheng M, et al. Epicardial adipose tissue thickness is a predictor for plaque vulnerability in patients with significant coronary artery disease. Atherosclerosis 2013; 226: 134-9.
12. Jacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pratic Cardiovasc 2005; 2: 536-543.
13. Khawaja T, Greer C, Chokshi A, et al. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol 2011; 108: 397-401.
14. Doesch C, Haghi D, Flchter S, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson 2010; 12: 40.
15. Campeau L. The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol 2002; 18: 371-9.
16. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6- minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-23.
17. Picard MH, Adams D, Bierig SM, et al. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr 2011; 24: 1-10.
18. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary [update 2005]: The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140.
19. Di Bari M, Pozzi C, Cavallini MC, et al. The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study. J Am Coll Cardiol 2004; 44: 1601-8.
20. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2009; 33: 62-69.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 7: 412-419.
23. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
24. Lau CH, Muniandy S. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. Cardiovasc Diabetol 2011; 10: 1-18.
25. Eroglu S, Sade LE, Yildirir A, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009; 19: 211-7.
26. Chaowalit N, Somers VK, Pellikka PA, et al. Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 2006; 186: 354-9.
27. Alexopoulos N, McLean DS, Janik M, Arepalli CD, Stillman AE, Raggi P. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis. 2010; 210: 150-4.
28. Gorter PM, Van Lindert AS, De Vos AM, et al. Quantification of epicardial and pericoronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome inpatients suspected of coronary artery disease. Atherosclerosis 2008; 197: 896-903.
29. Ross R, Leger L, Morris D, et al. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992; 72: 787-95.
30. Wasada T. Adenosine Triphosphate-Sensitive Potassium (KATp) Channel Activity is Coupled with Insulin Resistance. Internal Medicine 2002; 41: 84-90.
31. Fehlman M, Freychet P. Insulin and glucagon stimulation of (Na+,K+)-ATPase transport activity in isolated rat hepatocytes. J Biol Chem 1981; 256: 7449-7453.
32. Gourley DRH, Bethea MD. Insulin effect on adipose tissue sodium and potassium. Proc Soc Exp Biol Med 1964; 115: 821-823.
33. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005; 90: 6300-2.
34. Wang CP, Hsu HL, Hung WC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol 2009; 70: 876-82.
35. Ahn SG, Lim HS, Joe DY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008; 94: 1-6.
36. Shimabukuro M, Hirata Y, Tabata M, et al. Epicardial Adipose Tissue Volume and Adipocytokine Imbalance Are Strongly Linked to Human Coronary Atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33:,1077-84.
37. Ärnlöv J, Lind L, Zethelius B et al. Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up. Am Heart J 2001; 142: 720-724.
38. Ärnlöv J, Lind L, Sundström J, Andren B, Vessby B, Lithell H. Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic dysfunction twenty years later. Nutr Metab Cardiovasc Dis 2005; 15: 242-9.
39. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246-2252.
40. Bell DS. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003; 26: 2433-2441.
41. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000; 101: 2981-2988.
42. Greulich S, Maxhera B, Vandenplas G, et al. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation 2012; 126: 2324-34.